Extract

Objective

To determine the effect of dapoxetine in the treatment of PE combined with chronic prostatitis.

Methods

A total of 190 outpatients with acquired PE combined with chronic prostatitis were employed in this study. They were randomly divided into the control group (n=95) and experimental group (n=95). The control group received conventional therapy including α-receptor blocker and antibiotics. The experimental group was given conventional therapy combined with dapoxetine. The Premature Ejaculation Diagnostic Tool (PEDT) and the National Institutes of Health-Chronic Prostatitis Symptom Index (NIH-CPSI)were performed before and 2/4 weeks after treatment to evaluate the symptoms and treatment outcomes.

Results

Before treatment, no significant difference of PEDT and NIH-CPSI scores was found between the two groups. There are no significant correlation between the scores by spearman‘s correlation(r=0.145,P=0.061) .After 2 weeks treatment, PEDT and NIH-CPSI scores were all improved in experimental group(P<0.001).In the control group, NIH-CPSI scores were improved (P=0.037), but PEDT scores were not improved(P=1.101).While no difference of the PEDT and NIH-CPSI scores were detected between the two groups(P=0.22 and P=0.60 respectively ). After 4 weeks treatment, PEDT and NIH-CPSI scores were still improved in experimental group (P<0.001). Moreover, PEDT and NIH-CPSI scores were also improved in control group(P<0.001).Although no significant difference were found between the two groups (P=0.237),while the quality of life scores and PEDT scores showed a better improvement than control group (P<0.001).No severe side effects were found in this clinical trial.

You do not currently have access to this article.